Literature DB >> 33464076

Extrusion Printed Scaffolds with Varying Pore Size As Modulators of MSC Angiogenic Paracrine Effects.

Taimoor H Qazi1,2, Liesbeth Tytgat3,4, Peter Dubruel3,4, Georg N Duda1,2, Sandra Van Vlierberghe3,4, Sven Geissler1,2,5.   

Abstract

Cell encapsulation in confining 3D hydrogels typically prevents encapsulated cells from spreading and establishing cell-cell contacts. Interactions with neighboring cells or with the extracellular matrix (ECM) influence the paracrine activity of mesenchymal stromal cells (MSCs), but how these interactions are regulated by structural properties of biomaterial scaffolds remains insufficiently explored. Here, we describe the use of extrusion-based 3D printing to fabricate acellular, gelatin-based scaffolds with programmed strut spacings of 400 (small), 500 (medium), and 600 μm (large). These scaffolds showed similar effective Young's moduli in the range of 2-5 kPa, and varied based on average pore size which ranged from ∼200 μm (small pore: SP) through ∼302 μm (medium pore: MP) to ∼382 μm (large pore: LP). When seeded with MSCs, pore size guided cell distribution on the scaffolds, with smaller pores preventing cell infiltration, medium ones causing cells to aggregate in between struts, and large ones causing cells to flow through after attachment on the struts. These changes in cell distribution regulated cell-cell and cell-matrix interactions at the gene level, as assessed by pathway focused PCR arrays. Medium pore size scaffolds stimulated the highest paracrine secretion of a panel of angiogenic cytokines. This enhancement of paracrine activity substantially improved endothelial cell migration in a chemotaxis assay, increased single cell migration kinetics such as velocity, and stimulated the formation of robust tubular structures. Together, these findings not only provide new insights on cellular interactions in scaffold environments but also demonstrate how 3D biomaterial design can instruct and enhance the regenerative paracrine activities of MSCs.

Entities:  

Keywords:  angiogenesis; cell therapy; cell−cell interactions; cell−matrix interactions; trophic effects

Year:  2019        PMID: 33464076     DOI: 10.1021/acsbiomaterials.9b00843

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  7 in total

1.  4D Printing of Extrudable and Degradable Poly(Ethylene Glycol) Microgel Scaffolds for Multidimensional Cell Culture.

Authors:  Connor E Miksch; Nathaniel P Skillin; Bruce E Kirkpatrick; Grace K Hach; Varsha V Rao; Timothy J White; Kristi S Anseth
Journal:  Small       Date:  2022-06-22       Impact factor: 15.153

2.  3D printing of bio-instructive materials: Toward directing the cell.

Authors:  Piotr Stanisław Zieliński; Pavan Kumar Reddy Gudeti; Timo Rikmanspoel; Małgorzata Katarzyna Włodarczyk-Biegun
Journal:  Bioact Mater       Date:  2022-04-23

3.  The healing of bone defects by cell-free and stem cell-seeded 3D-printed PLA tissue-engineered scaffolds.

Authors:  Marjan Bahraminasab; Athar Talebi; Nesa Doostmohammadi; Samaneh Arab; Ali Ghanbari; Sam Zarbakhsh
Journal:  J Orthop Surg Res       Date:  2022-06-20       Impact factor: 2.677

Review 4.  Engineering the MSC Secretome: A Hydrogel Focused Approach.

Authors:  Marissa E Wechsler; Varsha V Rao; Alexandra N Borelli; Kristi S Anseth
Journal:  Adv Healthc Mater       Date:  2021-02-17       Impact factor: 9.933

Review 5.  Hydrogel Encapsulation: Taking the Therapy of Mesenchymal Stem Cells and Their Derived Secretome to the Next Level.

Authors:  Yuling Huang; Xin Li; Lina Yang
Journal:  Front Bioeng Biotechnol       Date:  2022-04-01

Review 6.  Biomaterials reinforced MSCs transplantation for spinal cord injury repair.

Authors:  Teng Ma; Jiahe Wu; Jiafu Mu; Jianqing Gao
Journal:  Asian J Pharm Sci       Date:  2021-04-20       Impact factor: 6.598

Review 7.  Adipogenesis or osteogenesis: destiny decision made by mechanical properties of biomaterials.

Authors:  Ting Su; Mimi Xu; Feng Lu; Qiang Chang
Journal:  RSC Adv       Date:  2022-08-30       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.